CervoMed Inc. Common Stock

CRVO XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

25M

Short interest (Jul 15)

8.9%

Net Short (Jul 27 ): 0.1%

Borrow Fee

101.45%

↓ 44.9%

Available Shares

400K

↑ 140.0%

Price Chart

Company Overview

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001053691

Asset Type: CS

Market Data

Market Cap: $24,628,192

Employees: 15

Status: Active

Short Interest

Current Borrow Fee 101.45%

Range: 101.45% - 103.63%

Available Shares 400K

Range: 200K - 800K

Recent Changes

Fee Change: ↓ 28.0%

Available Change: ↓ 26.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime